Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis E Echeverria

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Infectious Disease Clinics of North America|February 5, 2019
American Trypanosomiasis (Chagas Disease)Luis E Echeverria, Carlos A Morillo
JACC. Case Reports|January 29, 2026
Iatrogenic Hepatocellular Adenoma in Relation to an Unusual Complication of Cardiac SurgeryLuis E Echeverria, Omar Nicolas Ferro-Peñuela, Angie Yarlady Serrano-García, et al.
Infection|October 22, 2024
Worldwide prevalence of chagas cardiomyopathy-an analysis from the global burden of disease datasetAbdul Mannan Khan Minhas, Rachel Marcus, Salim S Virani, et al.
Heart (British Cardiac Society)|April 3, 2019
Risk factors for longitudinal changes in left ventricular diastolic function among women and menOscar L Rueda-Ochoa, Marco A Smiderle-Gelain, Dimitris Rizopoulos, et al.
Journal of the American College of Cardiology|March 18, 2026
Comparative Prognosis of Chagas and Other CardiomyopathiesRyohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.
Cardiology Research|May 15, 2025
Epidemiology and Short-Term Outcomes of Heart Failure With Preserved and Mildly Reduced Ejection Fraction in Colombia: Insights of the Colombian Heart Failure Registry (RECOLFACA)Lisbeth N Morales-Rodriguez, Alex Rivera-Toquica, Clara Saldarriaga, et al.
Journal of the American College of Cardiology|February 25, 2017
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS TrialCarlos A Morillo, Hetty Waskin, Sergio Sosa-Estani, et al.
JACC. Heart Failure|August 7, 2024
Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF TrialEdimar Alcides Bocchi, Luis E Echeverria, Caroline Demacq, et al.
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
Journal of the American College of Cardiology|September 1, 2022
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection FractionJawad H Butt, Pooja Dewan, Pardeep S Jhund, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Infectious Disease Clinics of North America|February 5, 2019
American Trypanosomiasis (Chagas Disease)Luis E Echeverria, Carlos A Morillo
JACC. Case Reports|January 29, 2026
Iatrogenic Hepatocellular Adenoma in Relation to an Unusual Complication of Cardiac SurgeryLuis E Echeverria, Omar Nicolas Ferro-Peñuela, Angie Yarlady Serrano-García, et al.
Infection|October 22, 2024
Worldwide prevalence of chagas cardiomyopathy-an analysis from the global burden of disease datasetAbdul Mannan Khan Minhas, Rachel Marcus, Salim S Virani, et al.
Heart (British Cardiac Society)|April 3, 2019
Risk factors for longitudinal changes in left ventricular diastolic function among women and menOscar L Rueda-Ochoa, Marco A Smiderle-Gelain, Dimitris Rizopoulos, et al.
Journal of the American College of Cardiology|March 18, 2026
Comparative Prognosis of Chagas and Other CardiomyopathiesRyohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.
Cardiology Research|May 15, 2025
Epidemiology and Short-Term Outcomes of Heart Failure With Preserved and Mildly Reduced Ejection Fraction in Colombia: Insights of the Colombian Heart Failure Registry (RECOLFACA)Lisbeth N Morales-Rodriguez, Alex Rivera-Toquica, Clara Saldarriaga, et al.
Journal of the American College of Cardiology|February 25, 2017
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS TrialCarlos A Morillo, Hetty Waskin, Sergio Sosa-Estani, et al.
JACC. Heart Failure|August 7, 2024
Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF TrialEdimar Alcides Bocchi, Luis E Echeverria, Caroline Demacq, et al.
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
Journal of the American College of Cardiology|September 1, 2022
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection FractionJawad H Butt, Pooja Dewan, Pardeep S Jhund, et al.
Pageof 2